µå·¯±×ÀÎÆ÷¸ÞÀÎ
 

»óº´Äڵ忡 µû¸¥ »óº´¸íÀ» È®ÀÎ ÇϽǼö ÀÖ½À´Ï´Ù.  
»óº´ÄÚµå ÇÑ±Û»óº´¸í ¿µ¹®»óº´¸í
C9200 AML1/ETO AML1/ETO
C9201 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´, inv(16)(p13:q22) Acute myeloid leukaemia, inv(16)(p13:q22)
C9201 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´, t(16:16)(p13:q11) Acute myeloid leukaemia, t(16:16)(p13:q11)
C9201 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´, CBF-beta/MYH11 Acute myeloid leukaemia, CBF-beta/MYH11
C9208 ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´[AML] Other and inspecigied acute myeloblastic leukaemia [AML]
C9208 ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´, ÃÖ¼ÒºÐÈ­ Acute myeloblastic leukaemia, minimal differentiation
C9208 ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´(¼º¼÷À» µ¿¹ÝÇÑ) Acute myeloblastic leukaemia (with maturation)
C9208 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M0 AML M0
C9208 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M1 AML M1
C9208 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M2 AML M2
C9208 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ (FABºÐ·ù¸¦ µ¿¹ÝÇÏÁö ¾ÊÀº) NOS AML (without FAB) NOS
C9208 º¯ÇüµÈ ¸ð¼¼Æ÷°úÀ×À» µ¿¹ÝÇÑ ºÒÀÀ¼ººóÇ÷ Refractory anaemia with excess blasts in transformation
C921 ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´[CML], BCR/ABL-¾ç¼º Chronic myeloid leukemia[CML],BCR/ABL-positive
C921 ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´, Çʶóµ¨ÇÇ¾Æ ¿°»öü ¾ç¼º Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive
C921 ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´, t(9:22)(q34:q11) Chronic myelogenous leukemia, t(9:22)(q34:q11)
C921 ¸ð¼¼Æ÷ÀÇ ¹ßÁõÀ» µ¿¹ÝÇÑ ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´ Chronic myelogenous leukemia with crisis of blast cells
C922 ºñÁ¤ÇüÀû ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´[CML], BCR/ABL À½¼º Atypical chronic myeloid leukemia[CML], BCR/ABL-negative
C923 °ñ¼ö¼º À°Á¾ Myeloid sarcoma
C923 ³ì»öÁ¾ Chloroma
C923 °ú¸³±¸¼º À°Á¾ Granulocytic sarcoma
2141  [2142] 2143  2144  2145  2146  2147  2148  2149  2150